Rosenbaum Jerrold F
Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.
J Clin Psychiatry. 2005;66 Suppl 2:4-8.
Benzodiazepines have been used extensively for the treatment of anxiety and related disorders since the 1960s. Although they have been proven to be effective as first-line treatment for anxiety disorders, during the 1980s public perception and concern for abuse liability and physical dependence with long-term use gave rise to a great deal of controversy. Negative perceptions toward the use of benzodiazepines for treating anxiety not only caused severely ill patients to go untreated or under-treated but also called into question whether the illness itself was worthy of treatment. Although new pharmacologic and psychological treatments for anxiety are available, psychopharmacologists continue to endorse benzodiazepines as primary or adjunct treatment for anxiety disorders. The intent of this article is to provide a historic overview of these issues and to offer some general clinical principles to help minimize the risk of abuse and dependence with benzodiazepine use.
自20世纪60年代以来,苯二氮䓬类药物已被广泛用于治疗焦虑症及相关疾病。尽管它们已被证明是治疗焦虑症的一线有效药物,但在20世纪80年代,公众对其滥用可能性和长期使用导致身体依赖的认知和担忧引发了大量争议。对使用苯二氮䓬类药物治疗焦虑症的负面看法不仅导致重症患者得不到治疗或治疗不足,还引发了对该疾病本身是否值得治疗的质疑。尽管有新的焦虑症药物和心理治疗方法,但精神药理学家仍继续支持将苯二氮䓬类药物作为焦虑症的主要或辅助治疗药物。本文旨在对这些问题进行历史性概述,并提供一些一般临床原则,以帮助将使用苯二氮䓬类药物时的滥用和依赖风险降至最低。